Elevated blood glucose during exacerbations of cystic fibrosis lung disease is associated with poor recovery of lung function.
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment.
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor
